Philippines approves Pfizer-BioNTech vaccine for emergency use

14 Jan 2021 / 12:01 H.

    MANILA, Jan 14 (Reuters) - The Philippines' Food and Drug Administration has authorized the emergency use of Pfizer Inc and BioNTech SE's COVID-19 vaccine, its head said on Thursday.

    The Pfizer-BioNTech vaccine, which has shown a 95% success rate, is the first vaccine the Philippines has approved.

    FDA head Rolando Enrique Domingo told a media briefing China's Sinovac Biotech Ltd on Wednesday submitted to regulators its emergency use authorization application. (Reporting by Karen Lema Editing by Ed Davies)

    email blast